Indication

Haemophilus influenzae lung abscess

*Haemophilus influenzae* lung abscess is a severe, localized lower respiratory tract infection characterized by microbial invasion and liquefactive necrosis of pulmonary parenchymal tissue, resulting in cavity formation containing purulent exudate. Read more about Haemophilus influenzae lung abscess

13 drugs 13 manufacturers

Advertisement

Drugs that treat it

Common Haemophilus influenzae lung abscess therapies.

Showing 10–13 of 13 drugs

Filter & compare in the drug finder →Opens the drug finder with Haemophilus influenzae lung abscess preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Haemophilus influenzae lung abscess.

*Haemophilus influenzae* lung abscess is a severe, localized lower respiratory tract infection characterized by microbial invasion and liquefactive necrosis of pulmonary parenchymal tissue, resulting in cavity formation containing purulent exudate.

Although pulmonary abscesses are predominantly polymicrobial or caused by anaerobes, this specific entity is driven by either encapsulated strains (such as type b) or nontypeable *H.

influenzae*, typically arising as a complication of necrotizing pneumonia, aspiration, or endobronchial obstruction.

It disproportionately impacts young children, the elderly, and individuals with underlying vulnerability, including structural lung disease, chronic obstructive pulmonary disease, or immunocompromising conditions.

Pathophysiologically and clinically, it is defined by intense suppurative inflammation, fever, productive cough with purulent sputum, pleuritic chest pain, and radiographic evidence of one or more thick-walled pulmonary cavities, often accompanied by an air-fluid level.

Personalize your experience

Follow Haemophilus influenzae lung abscess and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it